Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome

Ropivacaine is commonly used for post-operative pain management. We describe a case of neuroleptic malignant-like syndrome in a woman administered ropivacaine delivered using a drug infusion balloon. The presenting symptoms were confusion, agitation and fever. Blood analysis showed elevated C-reacti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miguel Santos, Sheila Arroja, Ana Luisa Antunes, Jose Mariz, Jorge Teixeira
Formato: article
Lenguaje:EN
Publicado: SMC MEDIA SRL 2021
Materias:
R
Acceso en línea:https://doaj.org/article/3382db5df67b4f2b8a235a4233985b26
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3382db5df67b4f2b8a235a4233985b26
record_format dspace
spelling oai:doaj.org-article:3382db5df67b4f2b8a235a4233985b262021-11-09T11:22:41ZRopivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome2284-259410.12890/2021_002971https://doaj.org/article/3382db5df67b4f2b8a235a4233985b262021-11-01T00:00:00Zhttps://www.ejcrim.com/index.php/EJCRIM/article/view/2971https://doaj.org/toc/2284-2594Ropivacaine is commonly used for post-operative pain management. We describe a case of neuroleptic malignant-like syndrome in a woman administered ropivacaine delivered using a drug infusion balloon. The presenting symptoms were confusion, agitation and fever. Blood analysis showed elevated C-reactive protein, leucocytosis and increased creatine phosphokinase. As intoxication was suspected, ropivacaine was suspended and the patient gradually improved. Possible leakage of ropivacaine into the intrathecal space may have resulted in central nervous system toxicity.Miguel SantosSheila ArrojaAna Luisa AntunesJose MarizJorge TeixeiraSMC MEDIA SRLarticleropivacaineintoxicationneuroleptic malignant syndromesecondary effectsMedicineRENEuropean Journal of Case Reports in Internal Medicine (2021)
institution DOAJ
collection DOAJ
language EN
topic ropivacaine
intoxication
neuroleptic malignant syndrome
secondary effects
Medicine
R
spellingShingle ropivacaine
intoxication
neuroleptic malignant syndrome
secondary effects
Medicine
R
Miguel Santos
Sheila Arroja
Ana Luisa Antunes
Jose Mariz
Jorge Teixeira
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
description Ropivacaine is commonly used for post-operative pain management. We describe a case of neuroleptic malignant-like syndrome in a woman administered ropivacaine delivered using a drug infusion balloon. The presenting symptoms were confusion, agitation and fever. Blood analysis showed elevated C-reactive protein, leucocytosis and increased creatine phosphokinase. As intoxication was suspected, ropivacaine was suspended and the patient gradually improved. Possible leakage of ropivacaine into the intrathecal space may have resulted in central nervous system toxicity.
format article
author Miguel Santos
Sheila Arroja
Ana Luisa Antunes
Jose Mariz
Jorge Teixeira
author_facet Miguel Santos
Sheila Arroja
Ana Luisa Antunes
Jose Mariz
Jorge Teixeira
author_sort Miguel Santos
title Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
title_short Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
title_full Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
title_fullStr Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
title_full_unstemmed Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
title_sort ropivacaine: an unusual cause of neuroleptic malignant-like syndrome
publisher SMC MEDIA SRL
publishDate 2021
url https://doaj.org/article/3382db5df67b4f2b8a235a4233985b26
work_keys_str_mv AT miguelsantos ropivacaineanunusualcauseofneurolepticmalignantlikesyndrome
AT sheilaarroja ropivacaineanunusualcauseofneurolepticmalignantlikesyndrome
AT analuisaantunes ropivacaineanunusualcauseofneurolepticmalignantlikesyndrome
AT josemariz ropivacaineanunusualcauseofneurolepticmalignantlikesyndrome
AT jorgeteixeira ropivacaineanunusualcauseofneurolepticmalignantlikesyndrome
_version_ 1718441096427601920